Oxxempic competitor: New weight-loss drug expected to get FDA approval in the coming months could poised to become the latest hot weight-loss drug

Ozempic competitor: New weight-loss drug expected to get FDA approval in coming months could be even more powerful than Wegovy

Wall Street Journal | 
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company ...
‘COVID booster strategy is not sustainable’: FDA pushes for long-term plans

‘COVID booster strategy is not sustainable’: FDA pushes for long-term plans

Wall Street Journal | 
A top U.S. health regulator said that asking people to frequently get Covid-19 boosters wasn’t sustainable because of vaccine fatigue and that ...
A pill for breast cancer? There's one for early-stage patients with aggressive cases — and it works

A pill for breast cancer? There’s one for early-stage patients with aggressive cases — and it works

Wall Street Journal | 
A drug sold by AstraZeneca and Merck & Co. reduced the recurrence of breast cancer in women with an early ...
‘A golden age of vaccinology’: Gene-based vaccines can combat infectious diseases of the future

‘A golden age of vaccinology’: Gene-based vaccines can combat infectious diseases of the future

Wall Street Journal | 
Johnson & Johnson’s Covid-19 vaccine, which was authorized [February 27] for use in the U.S., is at the vanguard of ...
mw in vaccin zq

Rival COVID vaccine developers issue joint pledge they will not seek government approval until immunizations proven ‘safe and effective’

Wall Street Journal | 
Nine drugmakers said Tuesday their chief executives signed a pledge promising to not file for regulatory approval or authorization of ...
antibodies covid teaser

How long will protective antibodies generated by a vaccine likely work?

Wall Street Journal | 
Only a handful of vaccines generate lifetime immunity for most people, such as the ones for measles, a viral infection ...
https://geneticliteracyproject.org/wp-content/uploads/2020/07/https-specials-images-forbesimg-com-imageserve-x--204x100.jpg

Testing irony: Explosion in new COVID-19 infections could speed up vaccine development

Wall Street Journal | 
More than 20 coronavirus vaccines are in human testing, according to the World Health Organization. So far, small, early studies of most ...
covid spikeproteins

Vaccine danger? Rare complications after getting a shot could increase severity of COVID-19

Wall Street Journal | 
Vaccines are designed to produce immune-system agents, including antibodies, that lock onto a virus and thereby neutralize it. In cases ...
bd cad f ea bffb a f ba

Three vaccines show the most promise in stimulating immune responses

Wall Street Journal | 
Vaccines being developed by University of Oxford researchers and AstraZeneca; Pfizer and German partner BioNTech; and China’s CanSino Biologics all ...
download

3 experimental COVID-19 vaccines set for critical testing phase this summer

Wall Street Journal | 
The federal government plans to fund and conduct the decisive studies of three experimental coronavirus vaccines starting this summer, according ...
ap sq b de b ffc b dd e b f b s c

First, we need a coronavirus vaccine. Then we need to figure out who gets it first

Wall Street Journal | 
Several drugmakers that have been building up their capabilities to make coronavirus vaccines, have pledged to deliver millions of doses ...
coronavirus drugs

Infographic: From vaccines to drugs, chasing ‘silver bullets’ targeting the fast-moving coronavirus

Wall Street Journal | 
For drug companies, there is suddenly only one priority: the coronavirus. More than 140 experimental drug treatments and vaccines for ...
cancer

Experimental drug targets 17 cancers sharing genetic defect

Wall Street Journal | 
An experimental drug shrank tumors in patients with a variety of cancers sharing the same genetic defect, new studies found, ...
wpid curata ffdef fe b e cf f e x

How will approval of first copycat biotech drug impact consumer costs?

Wall Street Journal | 
The Food and Drug Administration approved the first copy of a biotechnology drug for the U.S. market, firing the starting ...

23andMe halts marketing efforts

Wall Street Journal | 
Genetic-test maker 23andMe Inc. said Monday, December 2, that it stopped all marketing of its service last week in response ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists